How does BioSense 2.0 support government-led health IT efforts (and Meaningful Use requirements)?
BioSense 2.0 can serve as your agency's "catcher's mitt" for the volume of new health data under CMS's Meaningful Use programs, thereby saving your agency from purchasing and maintaining additional servers or other infrastructure required for managing an increased data volume. (Also, eligible providers (EDs or outpatient) can be incentivized and vendors can be certified when sending to this state-controlled environment—so it's a win-win).
How can BioSense 2.0 help hospital providers meet Meaningful Use for syndromic surveillance?
If a state or local health department chooses to use BioSense 2.0 as the receiver for syndromic surveillance data, hospitals may send data directly to the BioSense system. However, the data will go into a designated, jurisdiction-controlled area, where health department representatives can then determine how to share the data with the BioSense 2.0 community. In this scenario, if the data coming to the jurisdiction-controlled area meet the criteria for Meaningful Use, then the hospitals will be eligible for certification, regardless of how data are shared with the larger BioSense 2.0 community. The health department will always act as the attesting body, as CDC is not currently considered an authorizing public health authority under Meaningful Use regulations for Syndromic Surveillance.
ISDS has developed syndromic surveillance technical standards and specifications. Eligible hospitals can learn what public health jurisdictions need from emergency departments and how these data are used in the ISDS Final Recommendation, Core Processes and EHR Requirements for Public Heath Syndromic Surveillance.
Where can I find information on what my health department needs to know about Meaningful Use?
You can click on the following links to Web pages on Meaningful Use:
For additional information, click here to read the following article: Classen and Bates (2011, September). Finding the meaning in meaningful use. New England Journal of Medicine,365(9):855-8.